Mini-Open Fascia Lata Interposition Graft Results In Superior 2-Year Clinical Outcomes When Compared to Arthroscopic Partial Repair for Irreparable Rotator Cuff Tear: A Single-Blind Randomized Controlled Trial

The continuous fragility index of outcomes in rotator cuff repair augmentation randomized trials: a systematic review

BACKGROUND

Symptomatic rotator cuff tears often undergo surgical repair, which may be paired with various augmentation strategies to enhance structural healing rates. While many randomized controlled trials (RCTs) evaluate augmentation techniques, the statistical robustness of many findings in these studies is unknown. This systematic review aims to evaluate the continuous fragility index (CFI) of RCTs on augmentation techniques for rotator cuff repairs.

METHODS

MEDLINE, Embase, and CENTRAL databases were comprehensively searched from inception to September 2023 for RCTs assessing the efficacy of at least 1 augmentation strategy during rotator cuff repair. Eligible studies reported at least 1 statistically significant finding for a continuous outcome. The CFI for eligible outcomes was calculated, with median CFI presented by type of augmentation and outcome. Multivariable regression was performed to identify associations between CFI and other outcome variables.

RESULTS

Nineteen RCTs (1305 patients) were included in the final analysis. The median CFI for the 86 outcomes analyzed was 5.85 (interquartile range [IQR]: 2.3-14.4). Augmentation-specific analysis demonstrated variability in CFIs, with the most robust outcomes found in platelet-rich plasma studies (median: 10.95; IQR: 3.3-19.0) and suture-spanning augmentation studies (median: 11.90; IQR: 11.45-14.35). Outcome-specific analysis demonstrated range of motion outcomes as most robust (median: 9.85; IQR: 7.58-14.0) and strength-related outcomes as most fragile (median: 2.00; IQR: 1.0-16.3). Multivariable regression identified larger sample size as a statistically significant predictor of greater CFI. Notably, loss to follow-up exceeded the CFI in 31.4% of outcomes.

CONCLUSION

The observed median CFI of 5.85 in augmentation trials is consistent with the CFI reported in orthopedic and sports medicine literature. However, almost a third of outcomes had a loss to follow-up exceeding their CFI, risking the reversal of study findings with more robust follow-up and outcomes. Clinicians and researchers should consider fragility in addition to P values when assessing study results, especially in the context of high loss to follow-up. Future trials should report the fragility of their findings.

One-Year Follow-Up Is Sufficient Time for Patient-Reported Outcomes Following Rotator Cuff Repair: A Systematic Review and Meta-analysis

PURPOSE

To perform a systematic review to determine whether there were clinically significant differences in patient-reported outcome measures from 1- to 2-year follow-up following rotator cuff repair (RCR).

METHODS

A literature search of 3 databases was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Randomized controlled trials (RCTs) reporting on patient-reported outcomes at the 1- and 2-year follow-up following RCR were included. Meta-analysis was performed, and a P value <.05 was considered statistically significant.

RESULTS

Nineteen randomized controlled trials with 2,110 patients were included. There was a statistically significant difference in American Shoulder and Elbow Score score between the 1-year (mean, 87) and 2-year (mean, 89.4) follow-up (P < .00001), but this did not reach the minimal clinically important difference. There was no statistically significant difference in visual analog scale pain score between the 1-year (mean, 0.9) and 2-year (mean, 0.8) follow-up (P = .10). Additionally, the differences in Simple Shoulder Test; University of California, Los Angeles score; Constant score; and Western Ontario Rotator Cuff index between the 1- and 2-year follow-up did not reach the minimal clinically important difference despite statistically significant differences.

CONCLUSIONS

Statistically significant differences in patient-reported outcomes are reported between the 1- and 2-year follow-up points, although these differences fail to reach minimally clinically important differences. As a result, the 1-year follow-up may be sufficient to determine clinical outcomes from RCR.

STUDY DESIGN

Level II, systematic review of randomized control trials.

Arthroscopy Honors 2025 Award-Winning Authors Across Diverse Platforms

With sincere appreciation to the Arthroscopy Association of North America Education Foundation for their support, we present Arthroscopy's 2025 Annual Awards for the best Clinical Research, Basic Science Research, Resident/Fellow Research, Systematic Review, and Podcast published in 2024, as well as the Most Downloaded and Most Cited papers published 5 years ago in Arthroscopy, and the Most Downloaded Arthroscopy Techniques article. In addition, as of January 1, 2025, we have updated our Editor-in-chief, Assistant Editor, and Deputy and Associate Editors disclosures of potential conflicts of interest as well as our journal masthead.

Editorial Commentary: Collagen Bridging of Massive Rotator Cuff Tears Using Fascia Lata Autograft Could Provide a Lasting Solution

Shoulder rotator cuff tears are ideally primarily repaired, but large and massive, chronic, and/or retracted tears result in challenges. In response, innovative solutions include superior capsular reconstruction, tendon transfer, subacromial balloon spacer placement, tuberoplasty, partial repair, and marginal convergence. A recent innovation is to use collagen tissue to bridge repair of compromised tendon. Recent research using fascia lata autograft for supraspinatus tendon reconstruction in a rat model has shown positive outcomes with structural similarity to the normal muscle-tendon interface, decreased fatty infiltration, and increased type I and III collagen, suggesting enhanced mechanical strength. In human subjects, the advantages of autograft outweigh harvest-site morbidity, noting that Dacron, Teflon, and xenograft show poor results. Ideally, a graft might be composed of a degradable scaffold, possess mechanical strength, and amalgamate stem cells, growth factors, and matrix proteins to facilitate host-tissue integration.

Superior Capsular Reconstruction Using an Acellular Dermal Xenograft or Allograft Improves Shoulder Function but Is Associated with a High Graft Failure Rate

Objectives: The purpose of the present study was to evaluate clinical and functional outcomes, graft integrity rate and progression of osteoarthritis after superior capsular reconstruction (SCR) at short-term follow-up. Methods: Consecutive patients that underwent SCR using an acellular dermal xeno- or allograft between May 2018 and June 2020 for the treatment of irreparable posterosuperior rotator cuff tears were included. Shoulder function (American Shoulder and Elbow Surgeons [ASES] score), pain (Visual Analog Scale [VAS] for pain) and active shoulder range of motion (ROM) were evaluated preoperatively and after a minimum of 24 months postoperatively. Isometric strength was measured at follow-up and compared to the contralateral side. Magnetic resonance imaging was performed to evaluate graft integrity and osteoarthritis progression (shoulder osteoarthritis severity [SOAS] score). Results: Twenty-two patients that underwent SCR using a xeno- (n = 9) or allograft (n = 13) were evaluated 33.1 ± 7.2 months postoperatively. Four patients in the xenograft group underwent revision surgery due to pain and range of motion limitations and were excluded from further analysis (revision rate: 18.2%). Shoulder function (ASES score: 41.6 ± 18.8 to 72.9 ± 18.6, p < 0.001), pain levels (VAS for pain: 5.8 ± 2.5 to 1.8 ± 2.0, p < 0.001) and active flexion (p < 0.001) as well as abduction ROM (p < 0.001) improved significantly from pre- to postoperatively. Active external rotation ROM did not improve significantly (p = 0.924). Isometric flexion (p < 0.001), abduction (p < 0.001) and external rotation strength (p = 0.015) were significantly lower in the operated shoulder compared to the non-operated shoulder. Ten shoulders demonstrated a graft tear at the glenoid (n = 8, 44.4%) or humerus (n = 2, 11.1%). Graft lysis was observed in seven shoulders (38.9%). The graft was intact in one shoulder (5.6%), which was an allograft. A significant progression of shoulder osteoarthritis was observed at follow-up (SOAS score: 42.4 ± 10.1 to 54.6 ± 8.4, p < 0.001). Conclusions: At short-term follow-up, SCR using an acellular dermal xeno- or allograft resulted in improved shoulder function and pain with limitations in active external rotation ROM and isometric strength. Graft failure rates were high and osteoarthritis progressed significantly. Level of Evidence: Retrospective cohort study, Level III.

Postoperative Antiosteoporotic Treatment with Zoledronic Acid Improves Rotator Cuff Healing but Does Not Improve Outcomes in Female Patients with Postmenopausal Osteoporosis: A Prospective, Single-Blinded, Randomized Study

PURPOSE

To investigate the effect of the antiosteoporotic agent zoledronic acid (ZA) on rotator cuff healing and clinical outcomes in patients with postmenopausal osteoporosis.

METHODS

We prospectively enrolled 138 female patients with postmenopausal osteoporosis who were scheduled to undergo arthroscopic rotator cuff repair (ARCR) from March 2020 to March 2021. Patients were randomly allocated to the ZA group (ARCR followed by intravenous ZA infusions at postoperative Day 1 and 1 year later) and the control group (ARCR alone). All patients were followed up for 24 months. Tendon healing was evaluated by ultrasonography at 6 weeks and 24 months after surgery. The American Shoulder and Elbow Surgeons (ASES) score, Western Ontario Rotator Cuff (WORC) index, and Numeric Rating Scale (NRS) for pain were recorded at each follow-up, and the minimal clinically important difference (MCID) was calculated.

RESULTS

A total of 124 patients were included in the final analysis, 61 in the ZA group and 63 in the control group. There was no statistically significant difference in participant characteristics between the 2 groups. The ZA group had a significantly higher tendon healing rate than the control group at 2 years after surgery (odds ratio = 5.0; 95% confidence interval [CI], 1.4-18.7; P = .014). Regarding clinical outcomes, 100% of patients exceeded the MCID in both groups, and no significant differences were found at 2 years after surgery between the 2 groups (ASES: 2.5 [95% CI, -2.2 to 7.2; P = .291]; WORC index: 4.5 [95% CI, -0.117 to 9.117; P = .056]; NRS: -0.1 [95% CI, -0.3 to 0.1; P = .394]).

CONCLUSIONS

Antiosteoporotic treatment with ZA reduced the retear rate but did not significantly influence the clinical outcomes after ARCR in female patients with postmenopausal osteoporosis. Outcomes of ARCR showed good results in both groups and exceeded the MCID.

LEVEL OF EVIDENCE

Level I, randomized controlled trial.

Editorial Commentary: Bridging Graft Techniques Improve Short-Term Outcomes for Irreparable Rotator Cuff Tear Repair

There is a growing need for nonarthroplasty treatment options for irreparable rotator cuff tears. Options include superior capsular reconstruction (SCR), tendon transfers, subacromial balloon spacer, bridge grafting, biological tuberoplasty, and partial rotator cuff repair with or without augmentation. In our experience, repair with marginal convergence techniques is superior to SCR; if there is enough tissue, repair is the preferred strategy. In an effort to improve outcomes after repair, there has been increased interest in the use of interposition or bridging graft (BG) techniques, in which an allograft or autograft is secured on the humerus laterally and to the remnant tendon medially. Interposition or bridging grafts can be used to supplement partial repair in an effort to replace the patient's own missing tissues, and restore the biomechanical force couple of the rotator cuff and create a humeral head-depressing spacer effect in the subacromial space. These techniques show promising results compared to superior capsular reconstruction. Various graft options for BG are available, including human dermal allograft, fascia lata autograft, and tenotomized biceps autograft. Multiple animal studies have demonstrated that interposition grafts can improve the biomechanical properties of the repair construct, and histological studies in animal models have shown evidence of tissue in-growth into the BG, which could lead to increased repair strength over time. Finally, recent studies suggest that a bridging graft may improve short-term outcomes compared to partial repair alone. It remains to be seen whether this difference is clinically meaningful and durable.